480
Views
0
CrossRef citations to date
0
Altmetric
Original Articles: Clinical Oncology

Comparison of prone and supine positioning for breast cancer radiotherapy using REQUITE data: dosimetry, acute and two years physician and patient-reported outcomes

ORCID Icon, ORCID Icon, , , , , , , , , , , , , , , , , , , , , , , ORCID Icon, , , , , & show all
Pages 1036-1044 | Received 28 Oct 2022, Accepted 15 Jul 2023, Published online: 07 Aug 2023

References

  • Darby S, McGale P, Correa C, et al. Effect of radiotherapy after breast-conserving surgery on 10-year recurrence and 15-year breast cancer death: meta-analysis of individual patient data for 10 801 women in 17 randomised trials. The Lancet. 2011;378(9804):1707–1716.
  • Darby SC, Ewertz M, McGale P, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Engl J Med. 2013;368(11):987–998. doi: 10.1056/NEJMoa1209825.
  • Aznar MC, Duane FK, Darby SC, et al. Exposure of the lungs in breast cancer radiotherapy: a systematic review of lung doses published 2010-2015. Radiother Oncol. 2017;126(1):148–154. doi: 10.1016/j.radonc.2017.11.022.
  • Henson KE, McGale P, Taylor C, et al. Radiation-related mortality from heart disease and lung cancer more than 20 years after radiotherapy for breast cancer. Br J Cancer. 2013;108(1):179–182. doi: 10.1038/bjc.2012.575.
  • Taylor CW, Zhe W, Macaulay E, et al. Exposure of the heart in breast cancer radiation therapy: a systematic review of heart doses published during 2003 to 2013. Int J Radiat Oncol Biol Phys. 2015;93(4):845–853. doi: 10.1016/j.ijrobp.2015.07.2292.
  • Kirby AM, Evans PM, Donovan EM, et al. Prone versus supine positioning for whole and partial-breast radiotherapy: a comparison of non-target tissue dosimetry. Radiother Oncol. 2010;96(2):178–184. doi: 10.1016/j.radonc.2010.05.014.
  • Lymberis SC, De Wyngaert JK, Parhar P, et al. Prospective assessment of optimal individual position (prone versus supine) for breast radiotherapy: volumetric and dosimetric correlations in 100 patients. Int J Radiat Oncol Biol Phys. 2012;84(4):902–909. doi: 10.1016/j.ijrobp.2012.01.040.
  • Osa EOO, Dewyngaert K, Roses D, et al. Prone breast intensity modulated radiation therapy: 5-year results. Int J Radiat Oncol Biol Phys. 2014;89(4):899–906. doi: 10.1016/j.ijrobp.2014.03.036.
  • Lai J, Zhong F, Deng J, et al. Prone position versus supine position in postoperative radiotherapy for breast cancer: a meta-analysis. Medicine (Baltimore). 2021;100(20):e26000. doi: 10.1097/MD.0000000000026000.
  • Wang X, Fargier-Bochaton O, Dipasquale G, et al. Is prone free breathing better than supine deep inspiration breath-hold for left whole-breast radiotherapy? A dosimetric analysis. Strahlenther Onkol. 2021;197(4):317–331. doi: 10.1007/s00066-020-01731-8.
  • Veldeman L, Schiettecatte K, De Sutter C, et al. The 2-year cosmetic outcome of a randomized trial comparing prone and supine whole-breast irradiation in large-breasted women. Int J Radiat Oncol Biol Phys. 2016;95(4):1210–1217.
  • Mulliez T, Veldeman L, van Greveling A, et al. Hypofractionated whole breast irradiation for patients with large breasts: a randomized trial comparing prone and supine positions. Radiother Oncol. 2013;108(2):203–208. doi: 10.1016/j.radonc.2013.08.040.
  • Vakaet V, Van Hulle H, Vergotte M, et al. 5-year outcomes of a randomized trial comparing prone and supine whole breast irradiation in large breasted women. Int J Radiation Oncol Biol Phys. 2021;110(3):766–771. doi: 10.1016/j.ijrobp.2021.01.026.
  • Vesprini D, Davidson M, Bosnic S, et al. Effect of supine vs prone breast radiotherapy on acute toxic effects of the skin among women with large breast size: a randomized clinical trial. JAMA Oncol. 2022;8(7):994–1000. doi: 10.1001/jamaoncol.2022.1479.
  • Seibold P, Webb A, Aguado-Barrera ME, et al. REQUITE: a prospective multicentre cohort study of patients undergoing radiotherapy for breast, lung or prostate cancer. Radiother Oncol. 2019;138:59–67. doi: 10.1016/j.radonc.2019.04.034.
  • De Langhe S, Mulliez T, Veldeman L, et al. Factors modifying the risk for developing acute skin toxicity after whole-breast intensity modulated radiotherapy. BMC Cancer. 2014;14(1):9. doi: 10.1186/1471-2407-14-711.
  • Rattay T, Seibold P, Aguado-Barrera ME, et al. External validation of a predictive model for acute skin radiation toxicity in the REQUITE breast cohort. Front Oncol. 2020;10:575909. doi: 10.3389/fonc.2020.575909.
  • De Santis MC, Bonfantini F, Di Salvo F, et al. Factors influencing acute and late toxicity in the era of adjuvant hypofractionated breast radiotherapy. Breast. 2016;29:90–95. doi: 10.1016/j.breast.2016.07.013.
  • Pignol JP, Olivotto I, Rakovitch E, et al. A multicenter randomized trial of breast intensity-modulated radiation therapy to reduce acute radiation dermatitis. J Clin Oncol. 2008;26(13):2085–2092. doi: 10.1200/JCO.2007.15.2488.
  • Sprangers MA, Groenvold M, Arraras JI, et al. The European Organization for Research and Treatment of Cancer breast cancer-specific quality-of-life questionnaire module: first results from a three-country field study. J Clin Oncol. 1996;14(10):2756–2768. doi: 10.1200/JCO.1996.14.10.2756.
  • Cardoso MJ, Cardoso J, Amaral N, et al. Turning subjective into objective: the BCCT.core software for evaluation of cosmetic results in breast cancer conservative treatment. Breast. 2007;16(5):456–461. doi: 10.1016/j.breast.2007.05.002.
  • Osoba D, Rodrigues G, Myles J, et al. Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol. 1998;16(1):139–144. doi: 10.1200/JCO.1998.16.1.139.
  • Paelinck L, Gulyban A, Lakosi F, et al. Does an integrated boost increase acute toxicity in prone hypofractionated breast irradiation? A randomized controlled trial. Radiother Oncol. 2017;122(1):30–36. doi: 10.1016/j.radonc.2016.12.023.
  • Brunt AM, Wheatley D, Yarnold J, et al. Acute skin toxicity associated with a 1-week schedule of whole breast radiotherapy compared with a standard 3-week regimen delivered in the UK FAST-Forward trial. Radiother Oncol. 2016;120(1):114–118. doi: 10.1016/j.radonc.2016.02.027.
  • Wöckel A, Schwentner L, Krockenberger M, et al. Predictors of the course of quality of life during therapy in women with primary breast cancer. Qual Life Res. 2017;26(8):2201–2208. doi: 10.1007/s11136-017-1570-0.
  • Urzúa A, Miranda-Castillo C, Caqueo-Urízar A, et al. Do cultural values affect quality of life evaluation? Soc Indic Res. 2013;114(3):1295–1313. doi: 10.1007/s11205-012-0203-9.
  • Taylor C, Duane FK, Dodwell D, et al. Estimating the risks of breast cancer radiotherapy: evidence from modern radiation doses to the lungs and heart and from previous randomized trials. J Clin Oncol. 2017;35(15):1641–1649. doi: 10.1200/JCO.2016.72.0722.
  • Bartlett FR, Colgan RM, Donovan EM, et al. The UK HeartSpare study (stage IB): randomised comparison of a voluntary breath-hold technique and prone radiotherapy after breast conserving surgery. Radiother Oncol. 2015;114(1):66–72. doi: 10.1016/j.radonc.2014.11.018.
  • Mulliez T, Veldeman L, Speleers B, et al. Heart dose reduction by prone deep inspiration breath hold in left-sided breast irradiation. Radiother Oncol. 2015;114(1):79–84. doi: 10.1016/j.radonc.2014.11.038.
  • Saini AS, Hwang CS, Biagioli MC, et al. Evaluation of sparing organs at risk (OARs) in left-breast irradiation in the supine and prone positions and with deep inspiration breath-hold. J Appl Clin Med Phys. 2018;19(4):195–204. doi: 10.1002/acm2.12382.
  • Kirby AM, Evans PM, Helyer SJ, et al. A randomised trial of supine versus prone breast radiotherapy (SuPr study): comparing set-up errors and respiratory motion. Radiother Oncol. 2011;100(2):221–226. doi: 10.1016/j.radonc.2010.11.005.
  • Bentzen SM, Dörr W, Anscher MS, et al. Normal tissue effects: reporting and analysis. Semin Radiat Oncol. 2003;13(3):189–202. doi: 10.1016/S1053-4296(03)00036-5.
  • Aaronson NK, Ahmedzai S, Bergman B, et al. The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-Life instrument for use in international clinical trials in oncology. J Natl Cancer Inst. 1993;85(5):365–376. doi: 10.1093/jnci/85.5.365.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.